TriNetX Named Best of Show Finalist at SCOPE: Advancing Clinical Trial Planning with Conversational AI and Enhanced API Capabilities
TriNetX is proud to announce that we were named a Best of Show Finalist at SCOPE, the summit for clinical ops executives, one of the industry’s premier events focused on advancing clinical operations and innovation. This recognition highlights our continued commitment...
Insights from the Healthcare System for Patient-Centric Trials at the Point of Care
Patient-centricity is everywhere in clinical research. But what does it actually look like inside real healthcare systems? In this episode of Inside the Trends, we move beyond theory to explore how clinical trials can truly align with the realities of patient...
Finding the Unfindable: How One Healthcare Organization is Using TriNetX to Identify Underdiagnosed Heart Disease
We’re proud to announce Worcestershire Acute Hospitals NHS Trust as our Q1 2026 Network Spotlight winner! Led by Dr. David Wilson, Consultant Cardiologist at Worcestershire Acute Hospitals NHS Trust, a groundbreaking quality improvement project is demonstrating how...
TriNetX Unveils Conversational AI Interface and Enhanced API Capabilities
Success achieved in reducing trial costs and timelines drives 2026 platform enhancements designed to democratize clinical research analytics. CAMBRIDGE, Mass., January 22, 2026 — TriNetX, driven by its vision of a connected world where data and intelligence power...
The Year Real-World Data Became Essential: The Resources That Captivated Our Community in 2025
As we step into 2026, the biopharma industry finds itself at a different starting line than anyone predicted just a year ago. As Director of Content & Communication at TriNetX, I’ve watched which resources captivated our community in 2025, and more...
Winning with RWE: What It Takes to Make Real-World Evidence Submission-Ready
When every respondent in a survey agrees, it’s more than a trend; it’s a mandate. In the 2025 TriNetX and studioID survey of 150 senior biopharma executives, all participants agreed that real-world evidence (RWE) has the potential to improve regulatory submissions....
Three Recognitions, One Mission: Accelerating Innovation Across the Global Healthcare Ecosystem
As 2025 wraps up, the TriNetX team is reflecting on a year of milestones, among them, being named to The Healthcare Technology Report’s Top 50 Healthcare Technology Companies list this November. Earlier this year, TriNetX was also recognized among the Top 25...
From Real-World Data to Virtual Twins: Building the Next Generation of Precision-Medicine Tools
Chimeric antigen receptor (CAR) T-cell therapy is among the most promising breakthroughs in modern oncology. By genetically engineering a patient’s T lymphocytes to recognize and destroy cancer cells, CAR T-cell therapy has redefined what is possible in adoptive...